Galenea and Otsuka Pharmaceutical have reported the further extension of their research and development collaboration through 2011. The latest extension increases the collaboration term to seven years and
Dicerna Pharmaceuticals (Dicerna) and Kyowa Hakko Kirin have entered into a research collaboration and license agreement for the research, development and commercialisation of drug delivery systems and DsiRNA
Novavax has reported positive results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of the H1N1 virus-like particle (VLP) pandemic
Novo Nordisk has received FDA has approval for 10mcg dose formulation of Vagifem (estradiol vaginal tablets) for the treatment of atrophic vaginitis due to menopause. The approval makes
Takeda Pharmaceutical Company (Takeda) is planning to establish a new commercial subsidiary in Brazil. The new subsidiary represents the 12th new strategic expansion since January 2009 including Canada,
AstraZeneca and Targacept have entered into a collaboration and license agreement for the global development and commercialisation of TC-5214, Targacept’s late-stage investigational product for major depressive disorder (MDD).
Santarus has reported that its collaboration partner, Cosmo Technologies (Cosmo), a subsidiary of Cosmo Pharmaceuticals has completed enrollment of 514 patients in the European Phase III clinical trial
Galapagos has achieved multiple milestones under its alliance agreement in rheumatoid arthritis (RA). Rportedly, The milestones trigger a cash payment of 10.2m to Galapagos. Earlier, in October 2007,
Bruker Daltonics has entered into a framework agreement with Synlab for molecular microbial identification based on Maldi-Tof mass spectrometry. Reportedly, both the companies have concluded a partnership agreement
Honeywell has entered into a multi-year distribution agreement with Pro-Lab Laboratuar Teknolojileri, which will distribute Honeywell’s Burdick & Jackson laboratory chemicals, solvents in Turkey. Burdick & Jackson solvents
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.